4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-010809
Chief Executive Officer gave up 1,204 shares (to pay taxes)
- Chief Executive Officer acquired 4,106 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-03-31 | Option exercise | +4,106 | 67,197 | D | ||
| Robinson Chandler Chief Executive Officer | 2025-03-31 | Shares withheld for taxes | −1,204 | $36.41 | $43,838 | 65,993 | D |
| Derivatives | |||||||
| Robinson Chandler Chief Executive Officer | 2025-03-31 | Option exercise · Restricted Stock Units | −4,106 | 94,669 | D | ||
Loading xslF345X05/rdgdoc.xml…